Daicel Corporation (DACHF) Stock

About Daicel Corporation

Daicel Corporation, a globally active company founded in Osaka, Japan, in 1919, operates across diverse sectors including medical/healthcare, smart technologies, safety solutions, advanced materials, and engineering plastics. Its extensive product range serves various industries across Japan, China, and international markets. The company provides cosmetic ingredients like 1,3-Butylene glycol and polyglycerin, alongside specialized chiral and achiral columns, analytical tools, reagents, and comprehensive services for analysis, purification, and synthesis. For the electronics industry, Daicel offers high-performance films, solvents for electronic materials, resist polymers, semiconductor cleaning agents, optical components, silver nanoparticle inks, and organic semiconductor devices. In safety applications, their portfolio includes inflators, pyro-fuses, and safety devices designed for non-mobility products. They also manufacture a wide array of chemical products such as acetic acid and its derivatives, cellulose acetate, cycloaliphatic epoxies, and caprolactone. Additionally, Daicel contributes to the health and wellness sector with nutraceuticals like ceramide from konjac root, equol from soybeans, and specialized supplement formulations such as DiSPERZiSTA. Their offerings further encompass engineering plastics, high-performance polymers, functional sheets, and packaging films, alongside advanced water treatment systems like UF membrane modules and ultra-fine bubble diffusers. These innovative products are vital for applications in transportation, electronics, medical care, personal care, daily life, and environmental and energy management. Formerly known as Daicel Chemical Industries, Ltd., the company adopted its current name in October 2011.

Daicel Corporation is headquartered in JP.

Daicel Corporation (DACHF) stock trades at $8.00 with a market capitalization of $2.04B. The stock is valued at a price-to-earnings (P/E) ratio of 38.20, price-to-book of 1.10, price-to-sales of 0.65. Over the past 52 weeks the stock has ranged between $8.00 and $10.69, and currently trades 25.2% below its 52-week high. It pays a dividend yielding 5.38%.

On profitability, Daicel Corporation generates a return on equity (ROE) of 2.75%, return on capital employed of 6.61%, an operating margin of 7.26%, a net profit margin of 1.76%.

Official website: www.daicel.com